Table 3.
pS/pT | P−3 | P−2 | P−1 | P0 | P +1 | P +2 | P +3 | Total | Amino Acid Pair |
---|---|---|---|---|---|---|---|---|---|
N- and C-Terminus Domains | |||||||||
S6 | 0 | 3 | 1 | 2 | 1 | 2 | 0 | 9 | D/S, Q/S |
S9 | 2 | 1 | 2 | 0 | 1 | 11 | 2 | 19 | P/S, V/S |
S15 | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 6 | L/S, Q/S |
T18 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 3 | E/T, F/T |
S20 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | D/S, F/S |
S33 | 1 | 2 | 0 | 1 | 1 | 3 | 1 | 9 | P/S, L/S |
S37 | 1 | 3 | 1 | 2 | 0 | 2 | 0 | 9 | P/S, Q/S |
S46 | 1 | 4 | 1 | 5 | 8 | 1 | 8 | 28 | P/S, L/S |
T55 | 1 | 4 | 2 | 0 | 5 | 0 | 2 | 14 | E/T, F/T |
T81 | 3 | 4 | 2 | 2 | 9 | 3 | 10 | 33 | P/T, P/T |
S99 | 6 | 3 | 6 | 4 | 1 | 4 | 7 | 31 | P/S, Q/S |
S106 | 0 | 3 | 11 | 8 | 5 | 3 | 6 | 36 | S/G, S/Y |
S313 | 4 | 6 | 8 | 4 | 1 | 3 | 2 | 28 | T/S, S/S |
S314 | 6 | 8 | 4 | 1 | 3 | 2 | 9 | 33 | S/S, S/S |
S315 | 8 | 4 | 1 | 3 | 2 | 9 | 3 | 30 | P/S, S/S |
S362 | 0 | 1 | 0 | 0 | 1 | 3 | 2 | 7 | S/G, R/S |
S366 | 2 | 3 | 2 | 2 | 0 | 0 | 0 | 9 | S/S, H/S |
S376 | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 4 | Q/S, T/S |
T377 | 0 | 0 | 2 | 0 | 0 | 2 | 0 | 4 | S/S, S/S |
S378 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 4 | T/S, R/S |
T387 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 2 | E/T, T/K |
S392 | 1 | 0 | 0 | 1 | 0 | 2 | D/S, D/S | ||
Sum (N- and C-terminus) | 41 | 54 | 44 | 38 | 41 | 50 | 54 | ||
Core Domain | |||||||||
S149 | 14 | 32 | 16 | 16 | 14 | 190 | 141 | 423 | D/S, T/S |
T150 | 32 | 16 | 16 | 14 | 190 | 141 | 36 | 445 | T/S, P/T |
T155 | 141 | 36 | 85 | 79 | 85 | 228 | 247 | 901 | S/G, R/S |
S183 | 18 | 88 | 13 | 6 | 39 | 16 | 15 | 195 | S/D, S/C |
T211 | 39 | 15 | 14 | 30 | 16 | 81 | 87 | 282 | T/N, F/T |
S215 | 16 | 81 | 87 | 86 | 94 | 16 | 45 | 425 | S/H, S/V |
S269 | 187 | 57 | 17 | 20 | 102 | 54 | 169 | 606 | N/S, F/S |
Sum (core domain) | 447 | 325 | 248 | 251 | 540 | 726 | 740 |
Based on IARC p53 mutation database Release R16, which contains 29573 somatic mutations in sporadic cancers reported [85].